Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 7 (4), e00581

The Spectrum of Genetic Variants and Phenotypic Features of Southeast Asian Patients With Noonan Syndrome


The Spectrum of Genetic Variants and Phenotypic Features of Southeast Asian Patients With Noonan Syndrome

Ai-Ling Koh et al. Mol Genet Genomic Med.


Background: Noonan syndrome (NS) is an autosomal dominant disorder that belongs to a group of developmental disorders called RASopathies with overlapping features and multiple causative genes. The aim of the study was to identify mutations underlying this disorder in patients from Southeast Asia and characterize their clinical presentations.

Methods: Patients were identified from the hospital's Genetics clinics after assessment by attending clinical geneticists. A targeted gene panel was used for next-generation sequencing on genomic DNA extracted from the blood samples of 17 patients.

Results: Heterozygous missense variants were identified in 13 patients: eight were in PTPN11, three in SOS1, and one each in RIT1 and KRAS. All are known variants that have been reported in patients with NS. Of the 13 patients with identified variants, 10 had short stature, the most common feature for NS. Four of the eight patients with PTPN11 variants had atrial septal defect. Only two had pulmonary stenosis which is reported to be common for PTPN11 mutation carriers. Another two had hypertrophic cardiomyopathy, a feature which is negatively associated with PTPN11 mutations.

Conclusions: Our study provides the mutation and phenotypic spectrum of NS from a new population group. The molecular testing yield of 76% is similar to other studies and shows that the targeted panel approach is useful for identifying genetic mutations in NS which has multiple causative genes. The molecular basis for the phenotypes of the remaining patients remains unknown and would need to be uncovered via sequencing of additional genes or other investigative methods.

Keywords: Noonan syndrome; RASopathies; genetic testing; molecular diagnosis.

Conflict of interest statement

None declared.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles


    1. Allanson J. E. (2007). Noonan syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 145C, 274–279. 10.1002/ajmg.c.30138 - DOI - PubMed
    1. Aoki Y., & Matsubara Y. (2013). Ras/MAPK syndromes and childhood hemato‐oncological diseases. International Journal of Hematology, 97, 30–36. 10.1007/s12185-012-1239-y - DOI - PubMed
    1. Aoki Y., Niihori T., Banjo T., Okamoto N., Mizuno S., Kurosawa K., … Matsubara Y. (2013). Gain‐of‐function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. American Journal of Human Genetics, 93, 173–180. 10.1016/j.ajhg.2013.05.021 - DOI - PMC - PubMed
    1. Bertola D. R., Yamamoto G. L., Almeida T. F., Buscarilli M., Jorge A. A., Malaquias A. C., … Pereira A. C. (2014). Further evidence of the importance of RIT1 in Noonan syndrome. American Journal of Medical Genetics. Part A, 164a, 2952–2957. 10.1002/ajmg.a.36722 - DOI - PubMed
    1. Calcagni G., Adorisio R., Martinelli S., Grutter G., Baban A., Versacci P., … Marino B. (2018). Clinical presentation and natural history of hypertrophic cardiomyopathy in RASopathies. Heart Failure Clinics, 14, 225–235. 10.1016/j.hfc.2017.12.005 - DOI - PubMed

Publication types